ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Hawaii » Ophthalmology

Top Ophthalmology Prescribers in Hawaii

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WORLDSTER LEE M D

Ophthalmology

8,817

$399K

1430
1391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 60%

$45
Average prescription price

Avg: $79

TROY TANJI M.D.

Ophthalmology

5,316

$541K

808
773 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 60%

$102
Average prescription price

Avg: $79

SHIGEMI SUGIKI MD

Ophthalmology

4,387

$283K

573
558 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

49%
prescriptions for brand name drugs

Avg: 60%

$64
Average prescription price

Avg: $79

SAMUEL LO O.D., M.D.

Ophthalmology

4,188

$413K

848
792 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 60%

$99
Average prescription price

Avg: $79

MICHAEL MIYASHIRO MD

Ophthalmology

3,535

$271K

646
632 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 60%

$77
Average prescription price

Avg: $79

MING CHEN MD

Ophthalmology

3,297

$332K

645
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 60%

$101
Average prescription price

Avg: $79

KEN LIN M.D.

Ophthalmology

3,240

$477K

408
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 60%

$147
Average prescription price

Avg: $79

HARVEY MINATOYA MD

Ophthalmology

2,726

$315K

437
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 60%

$115
Average prescription price

Avg: $79

JIVIN TANTISIRA M.D.

Ophthalmology

2,676

$263K

553
522 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 60%

$98
Average prescription price

Avg: $79

MARGARET CHEUNG M.D.

Ophthalmology

2,529

$229K

522
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 60%

$90
Average prescription price

Avg: $79

RICK CARPENTER D.O.

Ophthalmology

2,528

$220K

478
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 60%

$87
Average prescription price

Avg: $79

CHRISTOPHER TORTORA M.D.

Ophthalmology

2,308

$140K

413
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 60%

$61
Average prescription price

Avg: $79

STEFAN KARAS M.D.

Ophthalmology

2,089

$165K

337
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 60%

$79
Average prescription price

Avg: $79

M PIERRE PANG M.D.

Ophthalmology

2,065

$161K

429
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 60%

$78
Average prescription price

Avg: $79

KENNETH BAUM MD

Ophthalmology

2,035

$68.9K

559
542 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 60%

$34
Average prescription price

Avg: $79

JASON TOKUNAGA MD

Ophthalmology

2,030

$146K

314
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 60%

$72
Average prescription price

Avg: $79

CARLTON YUEN M.D.

Ophthalmology

1,937

$124K

415
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 60%

$64
Average prescription price

Avg: $79

MARSHALL KIM M.D., PH.D.

Ophthalmology

1,920

$155K

358
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 60%

$81
Average prescription price

Avg: $79

JEFFREY MAEHARA MD

Ophthalmology

1,899

$139K

318
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $79

KENNETH LEE M.D.

Ophthalmology

1,856

$159K

343
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

60%
prescriptions for brand name drugs

Avg: 60%

$86
Average prescription price

Avg: $79

GREGORY SCHMIDT M.D.

Ophthalmology

1,783

$171K

342
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 60%

$96
Average prescription price

Avg: $79

HUGO HIGA M.D.

Ophthalmology

1,632

$121K

385
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 60%

$74
Average prescription price

Avg: $79

CARLOS OMPHROY M. D.

Ophthalmology

1,613

$118K

343
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $79

KARL HOLZINGER M.D.

Ophthalmology

1,601

$127K

434
371 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 60%

$80
Average prescription price

Avg: $79

ALAN FAULKNER M.D.

Ophthalmology

1,556

$166K

343
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

91%
prescriptions for brand name drugs

Avg: 60%

$107
Average prescription price

Avg: $79

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank